Chengdu Baiyu Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Chengdu Baiyu Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 15 active records with this name as holder; 29 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
26 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Dronedarone Hydrochloride Tablets 1 records · Latest accepted 2026/09/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602341 | Generic | 2026/09/20 | Chengdu Baiyu Pharmaceutical Co., Ltd.; Chengdu Di Yi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
注射用复方甘草酸苷 · No verified English name 3 records · Latest accepted 2026/02/25
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600374 | Supplement | 2026/02/25 | Chengdu Baiyu Pharmaceutical Co., Ltd.; Reyoung Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2600373 | Supplement | 2026/02/25 | Chengdu Baiyu Pharmaceutical Co., Ltd.; Reyoung Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2600372 | Supplement | 2026/02/25 | Chengdu Baiyu Pharmaceutical Co., Ltd.; Reyoung Pharmaceutical Co., Ltd. | CDE ↗ |
银杏总内酯 · No verified English name 1 records · Latest accepted 2025/04/22
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2500017 | New drug | 2025/04/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
银杏总内酯滴丸 · No verified English name 1 records · Latest accepted 2025/04/22
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXZS2500018 | New drug | 2025/04/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Neostigmine Methylsulfate Injection 3 records · Latest accepted 2024/07/30
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402410 | Generic | 2024/07/30 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402409 | Generic | 2024/07/30 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402408 | Generic | 2024/07/30 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Dopamine Hydrochloride Injection 2 records · Latest accepted 2023/12/30
Generic · 2
Dobutamine Hydrochloride Injection 1 records · Latest accepted 2023/12/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303576 | Generic | 2023/12/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
BY101298胶囊 · No verified English name 4 records · Latest accepted 2023/12/09
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301366 | New drug | 2023/12/09 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2301365 | New drug | 2023/12/09 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300023 | New drug | 2023/01/07 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300022 | New drug | 2023/01/07 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Magnesium Sulfate Injection 1 records · Latest accepted 2023/12/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303410 | Generic | 2023/12/09 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
BY101921片 · No verified English name 2 records · Latest accepted 2023/10/21
New drug · 2
Memantine Hydrochloride Tablets 2 records · Latest accepted 2022/11/11
Generic · 2
Doxofylline Injection 1 records · Latest accepted 2022/04/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250218 | Supplement | 2022/04/18 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Peramivir Injection 1 records · Latest accepted 2021/10/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101912 | Generic | 2021/10/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Dimethyl Fumarate Delayed-release Capsules 2 records · Latest accepted 2021/10/19
Generic · 2
Tolvaptan Tablets 1 records · Latest accepted 2021/01/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100092 | Generic | 2021/01/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
1 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 1 application
- 2026/09/20Accepted
Dronedarone Hydrochloride Tablets
CYHS2602341
Fact date: 2026/09/20 · Date added to this site: 2026/10/21
View source ↗
Under review
3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Dronedarone Hydrochloride Tablets | CYHS2602341 | Generic | 2026/09/20 | Chengdu Baiyu Pharmaceutical Co., Ltd.; Chengdu Di Yi Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| 银杏总内酯滴丸 · No verified English name | CXZS2500018 | New drug | 2025/04/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 银杏总内酯 · No verified English name | CXZS2500017 | New drug | 2025/04/22 | Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
15 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Magnesium Sulfate Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20255063 | 2025/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dobutamine Hydrochloride Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20254389 | 2025/05/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Memantine Hydrochloride Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized | 国药准字H20249194 | 2024/10/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Peramivir Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20233678 | 2023/06/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20233149 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20233148 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pramipexole Dihydrochloride Prolonged-release Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20233147 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tolvaptan Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20223417 | 2022/06/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ticagrelor Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20223117 | 2022/03/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apixaban Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20223077 | 2022/02/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20213894 | 2021/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lansoprazole For Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20143293 | 2021/06/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20213308 | 2021/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ambroxol Hydrochloride Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20103255 | 2021/03/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pantoprazole Sodium For Injection | Chengdu Baiyu Pharmaceutical Co., Ltd. | Chengdu Baiyu Pharmaceutical Co., Ltd. | 国药准字H20143128 | 2021/01/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
29 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 盐酸米安色林 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20260000204 | I | 2026/03/25 | CDE ↗ |
| 乳糖酸红霉素 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20260000044 | I | 2026/01/30 | CDE ↗ |
| 溴吡斯的明 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250001404 | I | 2026/01/15 | CDE ↗ |
| 利可君 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250000786 | I | 2025/09/19 | CDE ↗ |
| 达普司他 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250000924 | I | 2025/09/05 | CDE ↗ |
| 坎格雷洛四钠 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250000845 | I | 2025/08/26 | CDE ↗ |
| 托伐普坦磷酸钠 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250000603 | I | 2025/08/05 | CDE ↗ |
| 德拉沙星葡甲胺 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20250000471 | I | 2026/01/29 | CDE ↗ |
| 甲磺酸沙芬酰胺 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20240000664 | I | 2024/08/13 | CDE ↗ |
| 甲硫酸新斯的明 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20240000332 | A | 2026/05/02 | CDE ↗ |
| 盐酸多巴酚丁胺 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20230000986 | A | 2026/09/12 | CDE ↗ |
| 吲哚菁绿 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20230000864 | A | 2025/04/15 | CDE ↗ |
| 盐酸多巴胺 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20230000830 | A | 2025/12/25 | CDE ↗ |
| 布立西坦 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20210000848 | I | 2023/06/13 | CDE ↗ |
| 阿普米司特 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20230000371 | A | 2025/03/16 | CDE ↗ |
| 多索茶碱 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20210001237 | A | 2025/12/31 | CDE ↗ |
| 富马酸二甲酯 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200001456 | A | 2023/08/30 | CDE ↗ |
| 托伐普坦 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200001333 | A | 2026/02/04 | CDE ↗ |
| 替格瑞洛 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200000686 | A | 2026/01/10 | CDE ↗ |
| 盐酸普拉克索 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200000230 | A | 2024/12/31 | CDE ↗ |
| 阿哌沙班 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200000486 | A | 2026/10/28 | CDE ↗ |
| 依托考昔 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20200000229 | A | 2026/09/21 | CDE ↗ |
| 依诺肝素钠 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20190009408 | A | 2025/12/23 | CDE ↗ |
| 依达拉奉 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20190008303 | A | 2025/12/23 | CDE ↗ |
| 利伐沙班 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20190000570 | A | 2026/03/17 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20170002178 | A | 2025/04/23 | CDE ↗ |
| 依诺肝素钠 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20170002026 | A | 2022/09/29 | CDE ↗ |
| 替加环素 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20170000244 | A | 2026/07/07 | CDE ↗ |
| 苯丁酸甘油酯 · No verified English name | Chengdu Baiyu Pharmaceutical Co., Ltd. | Y20260000913 | I | 2026/11/11 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
47 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 富马酸伊布利特注射液 · No verified English name | CYHS2601741 | Generic | 2026/07/21 | Guangzhou Rui Er Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nicardipine Hydrochloride Injection | CYHB2601331 | Supplement | 2026/07/13 | Ji Ning Shen Zhou Pharmaceuticals Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nafamostat Mesilate for Injection | CYHS2601592 | Generic | 2026/07/06 | Chengdu Yao Yi Li Kang Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用托伐普坦磷酸钠 · No verified English name | CYHS2601440 | Generic | 2026/06/17 | Hua Bei Pharmaceutical Group Xin Yao Research Kai Fa Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Chloroprocaine Hydrochloride Injection | CYHS2601237 | Generic | 2026/06/01 | Chengdu Rui Er Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Diphenhydramine Hydrochloride Injection | CYHS2503453 | Generic | 2025/09/18 | Sichuan Tian Xing Hui Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2502910 | Generic | 2025/08/11 | Chongqing Kang Ke Er Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Acetylcysteine Injection | CYHS2502303 | Generic | 2025/06/27 | Sichuan Xin Tuo Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Bumetanide Injection | CYHS2501389 | Generic | 2025/04/10 | Hefei Yuan Feng Shun Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Peramivir Injection | CYHS2501319 | Generic | 2025/04/08 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Edaravone and Dexborneol Concentrated Solution for Injection | CYHS2501041 | Generic | 2025/03/13 | Fujian Da Pu Biopharmaceuticals Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 维生素B12注射液 · No verified English name | CYHS2500788 | Generic | 2025/02/19 | Beijing Bai Ya Joint Drug Research Institute Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Scopolamine Butylbromide Injection | CYHS2500546 | Generic | 2025/01/27 | Sichuan Wo Xiang Biopharmaceuticals Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cetirizine Hydrochloride Injection | CYHB2500198 | Supplement | 2025/01/24 | Shandong Ke Xin Hui Yi Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Injection | CYHB2401667 | Supplement | 2024/10/16 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Aminocaproic Acid Injection | CYHS2403337 | Generic | 2024/10/09 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Isoniazid Injection | CYHS2403311 | Generic | 2024/09/30 | Hebei Sai Pu Yi Hui Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 盐酸纳美芬注射液 · No verified English name | CYHS2403300 | Generic | 2024/09/30 | Chengdu Ming De Zhi Yuan Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Nicardipine Hydrochloride Injection | CYHS2402920 | Generic | 2024/09/05 | Chengdu Ming De Zhi Yuan Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Diprophylline Injection | CYHS2401173 | Generic | 2024/04/19 | Sichuan Tian Xing Hui Pharmaceuticals Technology Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 维生素B6注射液 · No verified English name | CYHS2400907 | Generic | 2024/03/26 | Beijing Bai Ya Joint Drug Research Institute Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Peramivir Injection | CYHB2301799 | Supplement | 2023/08/15 | Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cetirizine Hydrochloride Injection | CYHS2300724 | Generic | 2023/03/07 | Shandong Ke Xin Hui Yi Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Doxofylline Injection | CYHB2202218 | Supplement | 2022/12/10 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Rivaroxaban Tablets | CYHB2202212 | Supplement | 2022/12/09 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用依诺肝素钠 · No verified English name | CYHB2202208 | Supplement | 2022/12/09 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Enoxaparin Sodium Injection | CYHB2202207 | Supplement | 2022/12/09 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Azithromycin For Injection | CYHB2202206 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Azithromycin For Injection | CYHB2202205 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Injection | CYHB2202200 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Injection | CYHB2202198 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ambroxol Hydrochloride Injection | CYHB2202197 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用克林霉素磷酸酯 · No verified English name | CYHB2202196 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用克林霉素磷酸酯 · No verified English name | CYHB2202195 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Pantoprazole Sodium For Injection | CYHB2202194 | Supplement | 2022/12/08 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Pantoprazole Sodium For Injection | CYHB2202121 | Supplement | 2022/11/19 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Apixaban Tablets | CYHB2202110 | Supplement | 2022/11/17 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ticagrelor Tablets | CYHB2202109 | Supplement | 2022/11/17 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用炎琥宁 · No verified English name | CYHB2202108 | Supplement | 2022/11/17 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用炎琥宁 · No verified English name | CYHB2202107 | Supplement | 2022/11/17 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Parecoxib Sodium for Injection | CYHB2201900 | Supplement | 2022/10/14 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Etoricoxib Tablets | CYHB2201891 | Supplement | 2022/10/14 | Sichuan Hong Ming Bo Si Pharma Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Tolvaptan Tablets | CYHB2201625 | Supplement | 2022/09/09 | Guilin Pharmaceutical Co.,Ltd.; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ropivacaine hydrochloride injection | CYHS2101445 | Generic | 2021/07/19 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ropivacaine hydrochloride injection | CYHS2101443 | Generic | 2021/07/19 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Tranexamic Acid Injection | CYHS2101442 | Generic | 2021/07/16 | Guangzhou Yi Pin Hong Pharmaceutical Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cetirizine Hydrochloride Injection | CXHB2101054 | Supplement | 2021/06/22 | Beijing Ke Xin Bi Cheng Pharmaceuticals Technology Development Co., Ltd. romanized; Chengdu Baiyu Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.